Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Chemicals Industry Analysis

UpdatedJun 21, 2026
DataAggregated Company Financials
Companies128
  • 7D-1.4%
  • 3M4.5%
  • 1Y8.8%
  • YTD14.1%

Over the last 7 days, the Chemicals industry has dropped 1.4%, driven by Linde declining 2.2%. In the past year, the industry has gained 8.8%. Looking forward, earnings are forecast to grow by 17% annually.

Industry Valuation and Performance

Has the U.S. Chemicals Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 21 Jun 2026US$826.8bUS$360.7bUS$11.6b26.5x71.1x2.3x
Tue, 19 May 2026US$828.6bUS$360.0bUS$11.4b26.3x72.5x2.3x
Thu, 16 Apr 2026US$846.5bUS$357.2bUS$7.3b29.1x116.6x2.4x
Sat, 14 Mar 2026US$818.9bUS$357.1bUS$7.4b28.2x110.3x2.3x
Mon, 09 Feb 2026US$807.4bUS$371.5bUS$7.3b25.4x111.2x2.2x
Wed, 07 Jan 2026US$737.2bUS$371.9bUS$11.0b24.9x67x2x
Fri, 05 Dec 2025US$716.6bUS$371.7bUS$11.0b23x65.3x1.9x
Sun, 02 Nov 2025US$724.5bUS$370.0bUS$13.3b24.7x54.4x2x
Tue, 30 Sep 2025US$764.7bUS$367.7bUS$15.5b25.8x49.2x2.1x
Thu, 28 Aug 2025US$801.7bUS$367.6bUS$15.5b27x51.6x2.2x
Sat, 26 Jul 2025US$795.7bUS$376.7bUS$17.9b24x44.5x2.1x
Mon, 23 Jun 2025US$759.4bUS$378.4bUS$18.1b21.4x41.9x2x
Wed, 21 May 2025US$774.9bUS$378.5bUS$17.1b22.9x45.2x2x
Fri, 18 Apr 2025US$717.6bUS$380.8bUS$23.0b17.4x31.2x1.9x
Sun, 16 Mar 2025US$783.9bUS$379.3bUS$22.8b21.4x34.3x2.1x
Tue, 11 Feb 2025US$812.6bUS$382.4bUS$22.7b21x35.9x2.1x
Thu, 09 Jan 2025US$775.0bUS$384.4bUS$23.5b19.1x33x2x
Sat, 07 Dec 2024US$846.8bUS$384.3bUS$23.4b22.6x36.1x2.2x
Mon, 04 Nov 2024US$854.8bUS$386.7bUS$24.5b24.4x34.9x2.2x
Wed, 02 Oct 2024US$890.7bUS$381.8bUS$23.8b25.4x37.5x2.3x
Fri, 30 Aug 2024US$861.0bUS$383.8bUS$23.4b25.5x36.7x2.2x
Sun, 28 Jul 2024US$836.8bUS$379.4bUS$23.4b27.4x35.7x2.2x
Tue, 25 Jun 2024US$815.6bUS$377.3bUS$23.4b25.8x34.8x2.2x
Thu, 23 May 2024US$832.5bUS$377.3bUS$23.4b26x35.5x2.2x
Sat, 20 Apr 2024US$804.5bUS$384.6bUS$25.6b20.6x31.4x2.1x
Mon, 18 Mar 2024US$837.9bUS$384.6bUS$25.4b20x33x2.2x
Wed, 14 Feb 2024US$774.8bUS$388.9bUS$31.6b18.4x24.5x2x
Fri, 12 Jan 2024US$795.9bUS$398.8bUS$31.9b20.3x24.9x2x
Sun, 10 Dec 2023US$770.6bUS$398.4bUS$31.6b19.6x24.4x1.9x
Tue, 07 Nov 2023US$744.7bUS$401.7bUS$29.4b16.1x25.3x1.9x
Thu, 05 Oct 2023US$741.4bUS$412.0bUS$31.2b15.6x23.7x1.8x
Sat, 02 Sep 2023US$798.8bUS$412.0bUS$31.2b16.7x25.6x1.9x
Mon, 31 Jul 2023US$839.2bUS$438.0bUS$37.7b14.5x22.3x1.9x
Wed, 28 Jun 2023US$798.1bUS$444.6bUS$39.1b12.9x20.4x1.8x
Price to Earnings Ratio

20.4x


Total Market Cap: US$798.1bTotal Earnings: US$39.1bTotal Revenue: US$444.6bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Chemicals Industry Price to Earnings3Y Average 49.7x202420252026
Current Industry PE
  • Investors are optimistic on the American Chemicals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 71.1x which is higher than its 3-year average PE of 49.7x.
  • The industry is trading close to its 3-year average PS ratio of 2.5x.
Past Earnings Growth
  • The earnings for companies in the Chemicals industry have declined 33% per year over the last three years,
  • Revenues have also declined 6.7% per year.
  • This means overall sales from these companies are declining and profits are subsequently falling as well.

Industry Trends

Which industries have driven the changes within the U.S. Materials industry?

US Market1.39%
Materials-0.25%
Chemicals-1.41%
Fertilizers and Agricultural Chemicals-0.16%
Specialty Chemicals-0.25%
Industrial Gases-1.84%
Commodity Chemicals-5.94%
Diversified Chemicals-19.33%
Industry PE
  • Investors are most optimistic about the Fertilizers and Agricultural Chemicals industry which is trading above its 3-year average PE ratio of 27.4x.
    • Analysts are expecting annual earnings growth of 15.2%, which is higher than its past year's earnings growth of 9.6% per year.
Forecasted Growth
  • Analysts are most optimistic on the Commodity Chemicals industry, expecting annual earnings growth of 38% over the next 5 years.
  • This is better than its past earnings decline of 11% per year.
  • In contrast, the Diversified Chemicals industry is expected to see its earnings decline by 6.9% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CTVA CortevaUS$78.593.2%
+US$1.6b		6.6%PE42x
ECL EcolabUS$269.121.4%
+US$1.0b		3.0%PE36x
SHW Sherwin-WilliamsUS$320.791.1%
+US$855.8m		-3.8%PE30.3x
ESI Element SolutionsUS$45.975.2%
+US$553.0m		114.0%PE75.3x
SOLS Solstice Advanced MaterialsUS$85.573.0%
+US$398.6m		n/aPE72.3x

Latest News

ALB
US$160.35
Albemarle
7D
-5.9%
1Y
183.0%
Analysis Article • 4h

Albemarle (ALB) Stock Could Be 24.6% Undervalued After Recent Share Price Weakness

Albemarle (ALB) has drawn fresh attention after recent share price weakness, with the stock down 6% over the past month and 4% over the past 3 months. This has prompted investors to reassess its valuation and business mix. See our latest analysis for Albemarle. Beyond the recent weakness, Albemarle’s 1 day share price return of down 3.73% and 7 day return of down 5.91% sit against a year to date share price gain of 11.41%. The 1 year total shareholder return of about 1.9x contrasts with...
CTVA
US$78.59
Corteva
7D
3.2%
1Y
6.6%
Analysis Article • 17h

Corteva (CTVA) Stock Could Be 13% Undervalued After FMC Herbicide Deal

Why the new FMC partnership matters for Corteva stock Corteva (CTVA) recently signed a multi-year, co-exclusive supply and license agreement with FMC Corporation for rimisoxafen herbicide technology, giving the company another tool in corn and soybean crop protection. The deal covers North and South American markets, includes a US$200 million prepurchase payment from Corteva, and allows both companies to create their own premix formulations. Commercial sales are targeted by the end of the...
WLK
US$80.28
Westlake
7D
-9.3%
1Y
11.5%
Narrative Update • Jun 19

WLK: Litigation Settlement And German Acquisition Will Support Future Stock Rebound

Analysts have trimmed their fair value estimate for Westlake to about $113.40 per share, down from roughly $114.29, pointing to updated assumptions around revenue growth, profit margins, the discount rate, and a higher future P/E multiple. What’s in the News for Westlake Westlake stock is reported to be down 13.5% since its last earnings release, after the company reported a wider adjusted loss per share than expected in Q1 2026, with net sales down year over year and softer results in the Performance and Essential Materials segment.
DOW
US$31.73
Dow
7D
-6.3%
1Y
14.3%
ICL
US$5.14
ICL Group
7D
-10.3%
1Y
-23.5%
ECL
US$269.12
Ecolab
7D
1.4%
1Y
3.0%
Narrative Update • Jun 17

ECL: Pricing Power And AI Data Center Cooling Will Drive Future Upside

Analysts have nudged their fair value estimate for Ecolab slightly higher to about $317 per share, reflecting updated assumptions around modestly stronger revenue growth, a slightly lower discount rate, and continued focus on pricing power and high-tech growth engines highlighted in recent research. Analyst Commentary Recent Street research on Ecolab highlights a mix of optimism and caution, with differing views on how much of the company’s pricing power, high-tech exposure, and margin recovery are already reflected in the current valuation.
LIN
US$512.15
Linde
7D
-2.2%
1Y
12.3%
Analysis Article • Jun 17

Linde (LIN) Stock Could Be 4.9% Undervalued As Space Launch Demand Draws Attention

Fresh analyst commentary on Linde (LIN) highlights its role in supplying industrial gases to the growing commercial space launch market, with expectations of a modest positive contribution to annual volume growth. See our latest analysis for Linde. Linde’s recent analyst attention around commercial space launch activity comes on top of strong share price momentum, with a roughly 21% year to date share price return and a 5 year total shareholder return close to 91%, suggesting that interest...
SHW
US$320.79
Sherwin-Williams
7D
1.1%
1Y
-3.8%
Narrative Update • Jun 17

SHW: Housing And Raw Material Headwinds Will Test Future Pricing Power

The analyst price target for Sherwin-Williams has been reduced by about $15 as analysts weigh lower fair value and P/E assumptions against updated expectations for revenue growth and profit margins in a more challenging housing and raw materials backdrop. Analyst Commentary Recent research on Sherwin-Williams highlights a mix of optimism and caution, with several firms adjusting price targets and ratings as they reassess valuation, housing exposure and raw material pressures.
LYB
US$60.07
LyondellBasell Industries
7D
-7.0%
1Y
3.0%
Narrative Update • Jun 16

LYB: Dividend Reset And Polyethylene Pricing Will Shape Future Share Performance

Analysts have increased their fair value estimate for LyondellBasell Industries stock from $38.00 to $63.00, citing updated views on polyethylene pricing, earnings normalization for chemicals, and revised P/E assumptions that are reflected in recent Street price target changes. Analyst Commentary Recent Street research on LyondellBasell Industries highlights a mix of optimism around polyethylene pricing and chemicals earnings, alongside more cautious views that focus on how long current conditions can last and what investors may be willing to pay for the stock.
SQM
US$79.69
Sociedad Química y Minera de Chile
7D
-5.3%
1Y
148.4%
PRM
US$37.78
Perimeter Solutions
7D
6.5%
1Y
184.5%
New Narrative • Jun 09

Long Term Fire Management Contracts Will Support More Stable Future Performance

Catalysts About Perimeter Solutions Perimeter Solutions provides fire retardants, fire suppressants and specialty chemicals that support wildfire management and industrial customers. What are the underlying business or industry changes driving this perspective?
CBT
US$91.80
Cabot
7D
4.7%
1Y
25.4%
New Narrative • Jun 09

Battery And Data Center Demand Will Support A Steady Long Term Materials Story

Catalysts About Cabot Cabot develops and supplies specialty materials, including reinforcement materials and performance chemicals used across batteries, tires, data centers and infrastructure applications. What are the underlying business or industry changes driving this perspective?
ESI
US$45.97
Element Solutions
7D
5.2%
1Y
114.0%
Narrative Update • Jun 07

ESI: Upcoming Analyst Day And Updated Assumptions Will Support Future Upside

Analysts have raised their price target for Element Solutions from $40.10 to $47.30, citing updated assumptions for revenue growth, profit margins and a lower implied future P/E multiple as key factors behind the change. What's in the News Element Solutions plans to hold an Analyst/Investor Day, giving you a closer look at the business, capital allocation priorities and updates on long term objectives.
CF
US$102.93
CF Industries Holdings
7D
-6.0%
1Y
2.6%
AXTA
US$34.78
Axalta Coating Systems
7D
5.0%
1Y
19.7%
Narrative Update • Jun 06

AXTA: Merger Progress And Mixed Rating Shifts Will Shape Repriced Expectations

Axalta Coating Systems' updated analyst price target edges higher by about $0.14 per share as analysts factor in slightly lower discount rate assumptions and modestly adjusted growth and P/E inputs following recent Street research, including Citi's renewed confidence in the potential Axalta and Akzo merger. Analyst Commentary Bullish Takeaways Bullish analysts point to the potential Axalta and Akzo merger as a key support for valuation, with some viewing the removal of other interested bidders for Akzo as reducing deal uncertainty.
SOLS
US$85.57
Solstice Advanced Materials
7D
3.0%
1Y
n/a
Seeking Alpha • May 26

Solstice: Expectations Run Hot

Summary Solstice, a recent Honeywell spin-off, delivered robust Q1 results with 10% sales growth and strong performance in refrigerants and nuclear segments. Despite healthy fundamentals and nuclear growth prospects, Solstice trades at a stretched 30x earnings multiple after a >60% YTD rally. Capital spending is set to outpace depreciation, with $400–$425 million planned in 2024, reflecting aggressive investment in growth initiatives. I remain cautious on Solstice due to elevated valuation, rising corporate costs, and the risk that current enthusiasm, especially around nuclear, may be overextended. Read the full article on Seeking Alpha